Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin for hospitalized COVID-19 patients
IRCT20200906048638N1Phase 4Completed
- Sponsor
- Qazvin University of Medical Sciences
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in coronavirus disease 2019 (COVID-19) comparing Atorvastatin with Placebo (2 arms). Primary endpoints: Duration of hospitalization, Blood oxygen saturation and 3 more. Started Dec 2020; status: completed.
02
Drugs
atorvastatin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20200906048638N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200906048638N1.